Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Cancers|November 6, 2020
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester DiseaseRan Weissman, Eli L Diamond, Julien Haroche, et al.
Blood Neoplasia|June 2, 2025
Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasmsAstrid G S van Halteren, Paul G Kemps, Jelske Forma-Borst, et al.
Nature|March 15, 2019
Efficacy of MEK inhibition in patients with histiocytic neoplasmsEli L Diamond, Benjamin H Durham, Gary A Ulaner, et al.
Blood|March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adultsGaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
Annals of Hematology|September 27, 2024
Rosai-Dorfman-Destombes disease in adults: a single center experienceEmily Leung, Collin Pryma, Stephen Murphy, et al.
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.
JAMA Oncology|December 1, 2017
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET StudyEli L Diamond, Vivek Subbiah, A Craig Lockhart, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.
Blood|July 7, 2017
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosisMatthias Papo, Eli L Diamond, Fleur Cohen-Aubart, et al.
Pageof 13